LY-dE#5

N/A

Report date: 2026/04/09 20:00:21

Base Information

Drug NameLY-dE#5
Drug Alias NameN/A
ClassificationBiologics > Lysosome-Targeting Chimaeras (LYTAC)
Mechanisms of ActionEpidermal growth factor receptor erbB1 degradersInsulin-like growth factor II receptor modulators
TargetsEpidermal growth factor receptor erbB1Insulin-like growth factor II receptor
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesShandong Normal University
China Registration ClassN/A

Develop Information

Active CompaniesShandong Normal University
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A